• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Palmitoylation of influenza virus proteins

tetano

Editor, Senior Moderator
Biochem Soc Trans. 2013 Feb 1;41(1):50-5. doi: 10.1042/BST20120210.
Palmitoylation of influenza virus proteins.
Veit M, Serebryakova MV, Kordyukova LV.
Source

*Department of Immunology and Molecular Biology Veterinary Faculty, Free University, Philippstr. 13, 10115 Berlin, Germany.
Abstract

Influenza viruses contain two palmitoylated (S-acylated) proteins: the major spike protein HA (haemagglutinin) and the proton-channel M2. The present review describes the fundamental biochemistry of palmitoylation of HA: the location of palmitoylation sites and the fatty acid species bound to HA. Finally, the functional consequences of palmitoylation of HA and M2 are discussed regarding association with membrane rafts, entry of viruses into target cells by HA-mediated membrane fusion as well as the release of newly assembled virus particles from infected cells.

PMID:
23356257
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23356257
 
Back
Top Bottom